Foghorn Therapeutics Inc.FHTXNASDAQ

Revenue (LTM)

$31M

+36.8% YoY

Net Income (LTM)

$-74M

+14.2% YoY

Free Cash Flow

$-86M

Revenue CAGR (5Y)

+135.1%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1	19↑1357.8%	34↑77.6%	23↓33.8%	31↑36.8%
Gross Profit	1	19↑1357.8%	34↑77.6%	23↓33.8%	28↑22.0%
Operating Income	-101	-117↓16.3%	-108↑7.9%	-103↑4.8%	-82↑20.0%
Net Income	-101	-109↓7.5%	-98↑9.6%	-87↑12.0%	-74↑14.2%
EBITDA	-96	-114↓18.3%	-104↑8.2%	-97↑7.0%	-79↑18.9%
EPS Diluted	-2.78	-2.62↑5.8%	-2.34↑10.7%	-1.58↑32.5%	-1.18↑25.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	101	52↓48.4%	80↑53.9%	55↓31.0%	81↑45.8%
Total Current Assets	460	351↓23.5%	240↓31.7%	250↑3.9%	163↓34.6%
Total Assets	520	405↓22.1%	286↓29.4%	284↓0.7%	198↓30.2%
Total Current Liabilities	49	55↑13.4%	58↑5.9%	67↑14.6%	60↓10.8%
Total Liabilities	423	405↓4.3%	363↓10.3%	330↓9.3%	307↓7.0%
Total Equity	97	0↓99.9%	-77↓69019.6%	-46↑41.0%	-109↓138.3%
Total Debt	58	52↓11.7%	45↓12.5%	37↓17.6%	41↑11.1%
Net Debt	-43	-1↑98.3%	-35↓4887.7%	-18↑48.0%	-40↓116.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-50	194↑485.3%	-118↓161.0%	-100↑15.0%	-86↑14.2%
Capital Expenditure	-3	-1↑63.5%	-1↓1.2%	-1↑26.0%	-0↑94.5%
Free Cash Flow	-54	192↑459.2%	-119↓162.0%	-101↑15.1%	-86↑15.0%
Stock-Based Comp	8	0	16	12↓26.5%	10↓12.6%
Net Change in Cash	8	-49↓686.5%	28↑157.5%	-25↓188.5%	27↑208.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance